ResMed Inc.RMDNYSE
Loading
SG&A Expense Growth TrendStable
Percentile Rank57
3Y CAGR-7.8%
5Y CAGR+10.4%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
-7.8%/yr
vs +5.3%/yr prior
5Y CAGR
+10.4%/yr
Recent deceleration
Acceleration
-13.1pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthStable
PeriodValue
20258.06%
20244.94%
202318.21%
202210.29%
2021-0.93%
20204.91%
20197.44%
20188.38%
201713.50%
20163.26%